81 related articles for article (PubMed ID: 25299561)
41. [Bladder contracture following intravesical BCG immunotherapy treated by hydrodistention: a case report].
Sawada A; Yagihashi Y; Kawase N; Fukuzawa S
Hinyokika Kiyo; 2006 Jan; 52(1):59-61. PubMed ID: 16479993
[TBL] [Abstract][Full Text] [Related]
42. Intravesical bacillus Calmette-Guerin immunotherapy after previous prostate radiotherapy for high-grade non-muscle-invasive bladder cancer.
Rao MV; Ellimoottil C; Sondej T; Flanigan RC; Quek ML
Urol Oncol; 2013 Aug; 31(6):857-61. PubMed ID: 21868262
[TBL] [Abstract][Full Text] [Related]
43. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
Steinbach F; Schuster F
Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
[TBL] [Abstract][Full Text] [Related]
44. Long-term follow-up of intravesical bacillus Calmette-Guérin treatment for superficial transitional-cell carcinoma of the bladder involving the prostatic urethra.
Taylor JH; Davis J; Schellhammer P
Clin Genitourin Cancer; 2007 Sep; 5(6):386-9. PubMed ID: 17956711
[TBL] [Abstract][Full Text] [Related]
45. A case of ureteral obstruction and sepsis induced by bladder perforation following intravesical bacillus Calmette-Guérin successfully treated with an antituberculous agent, antimicrobial chemotherapy and percutaneous urine drainage.
Morooka D; Nishiyama N; Hiyama Y; Masumori N
Int Cancer Conf J; 2018 Jul; 7(3):103-106. PubMed ID: 31149525
[TBL] [Abstract][Full Text] [Related]
46. A 2-week maintenance regimen of intravesical instillation of bacillus Calmette-Guerin is safe, adherent and effective in patients with non-muscle-invasive bladder cancer: a prospective, multicenter phase II clinical trial.
Kanagawa Urological Research Group (KURG)
Jpn J Clin Oncol; 2012 Sep; 42(9):813-9. PubMed ID: 22761255
[TBL] [Abstract][Full Text] [Related]
47. Systemic BCG-Osis as a Rare Side Effect of Intravesical BCG Treatment for Superficial Bladder Cancer.
Lukacs S; Tschobotko B; Szabo NA; Symes A
Case Rep Urol; 2013; 2013():821526. PubMed ID: 23844314
[TBL] [Abstract][Full Text] [Related]
48. Secondary Haemophagocytic Lymphohistiocytosis Syndrome (HLH) After Intravesical Instillation of Bacillus Calmette-Guérin (BCG): A Case Report and Review of the Literature.
Manganas K; Angelara M; Bountzona I; Karamanakos G; Toskas A
Eur J Case Rep Intern Med; 2022; 9(10):003395. PubMed ID: 36415837
[TBL] [Abstract][Full Text] [Related]
49. Disseminated Granulomatous Disease from Intravesical Instillation of Bacillus Calmette-Guerin.
Ghafouri SAR; Brun A; Bhalla R; Margulies C; Skole K
Case Rep Oncol Med; 2018; 2018():8280527. PubMed ID: 30245898
[TBL] [Abstract][Full Text] [Related]
50. Haemophagocytic lymphohistiocytosis after intravesical BCG administration for bladder cancer presenting with multiorgan failure.
Liatsos GD; Manousopoulou G; Poulaki A; Iliaki A; Mariolis I; Vassilopoulos D
Access Microbiol; 2023; 5(9):. PubMed ID: 37841100
[TBL] [Abstract][Full Text] [Related]
51. Managing the adverse events of intravesical bacillus Calmette-Guérin therapy.
Decaestecker K; Oosterlinck W
Res Rep Urol; 2015; 7():157-63. PubMed ID: 26605208
[TBL] [Abstract][Full Text] [Related]
52. A case of BCG sepsis with bone marrow and liver involvement after intravesical BCG instillation.
Dederke B; Riecken EO; Weinke T
Infection; 1998; 26(1):54-7. PubMed ID: 9505183
[TBL] [Abstract][Full Text] [Related]
53. Acute Hepatitis and Pneumonitis Caused by Disseminated Bacillus Calmette-Guérin Infection.
Dibs K; Shehadeh I; Abu Atta O
ACG Case Rep J; 2016 Jan; 3(2):130-2. PubMed ID: 26958569
[TBL] [Abstract][Full Text] [Related]
54. Caseating granulomas on the glans penis as a complication of bacille calmette-guérin intravesical therapy.
French CG; Hickey L; Bell DG
Rev Urol; 2001; 3(1):36-8. PubMed ID: 16985688
[TBL] [Abstract][Full Text] [Related]
55. Reactive Arthritis - A Rare Complication of Intravesical BCG Instillation.
Freixa M; Úria S; da Silva GN
Eur J Case Rep Intern Med; 2020; 7(3):001448. PubMed ID: 32206642
[TBL] [Abstract][Full Text] [Related]
56. Favorable Outcome in a Patient with Systemic BCGitis After Intra-bladder Instillation of Calmette-Guerin Bacillus Highlighting the Importance of Making the Correct Diagnosis in this Rare Form of Sepsis.
Attou R; Albrich T; Kadou J; Redant S; Honoré PM; De Bels D
J Transl Int Med; 2019 Mar; 7(1):34-38. PubMed ID: 30997355
[TBL] [Abstract][Full Text] [Related]
57. Case Presentation: Lung Consolidation as Sequelae of BCG Sepsis After Combined Intravesical and Intraurethral BCG.
Strich J; Brancato S; Dolan R; Maruf M; Siddiqui MR; Sanford T; Zerbe C; Agarwal PK
Urol Case Rep; 2017 Jul; 13():152-153. PubMed ID: 28567334
[TBL] [Abstract][Full Text] [Related]
58. Fatal sepsis by Bacillus circulans in an immunocompromised patient.
Alebouyeh M; Gooran Orimi P; Azimi-Rad M; Tajbakhsh M; Tajeddin E; Jahani Sherafat S; Nazemalhosseini Mojarad E; Zali M
Iran J Microbiol; 2011 Sep; 3(3):156-8. PubMed ID: 22347600
[TBL] [Abstract][Full Text] [Related]
59. Disseminated BCG sepsis following intravesical therapy for Bladder Carcinoma: A case report and review of literature.
Oladiran O; Nwosu I; Oladunjoye A; Oladunjoye O
J Community Hosp Intern Med Perspect; 2020 May; 10(2):168-170. PubMed ID: 32850058
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
